Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLS003 (Digoxin/Furosemide) in HPV-induced Genital Lesions
NCT03334240Phase 2Terminated
- Sponsor
- Maruho Co., Ltd.
- Start
- Oct 2017
- Primary completion
- Oct 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of digoxin, furosemide in condylomata acuminata, Vulvar Squamous Intraepithelial Neoplasia (VIN), sponsored by Maruho Co., Ltd.. Started Oct 2017; status: terminated.
02
Drugs
digoxinfurosemide
03
Conditions
condylomata acuminataVulvar Squamous Intraepithelial Neoplasia (VIN)
Beyond the preview
Go deeper on NCT03334240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03334240.